These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25710358)

  • 1. AMP-deaminase from thymus of patients with myasthenia gravis.
    Rybakowska I; Szydłowska M; Szrok S; Bakuła S; Kaletha K
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(3):229-34. PubMed ID: 25710358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myoadenylate deaminase deficiency among patients with myasthenia gravis--preliminary results of exercise].
    Bilińska M; Chodorowski Z; Nyka W; Nyka W; Rybakowska I; Smoleński R; Kaletha K
    Przegl Lek; 2003; 60(11):724-5. PubMed ID: 15058043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The thymus and myasthenia gravis.
    Taha AM; Haddad R; Allam C; Baraka A
    Middle East J Anaesthesiol; 1981 Jun; 6(2):99-112. PubMed ID: 7334939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of AMP-deaminase and cytosolic 5'-nucleotidase genes in human term placenta.
    Roszkowska A; Klimek J; Kaletha K
    Mol Cell Biochem; 2008 Apr; 311(1-2):249-51. PubMed ID: 18165923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased mast cell density and microvessel density in the thymus of patients with myasthenia gravis.
    Raica M; Cîmpean AM; Encică S; Scridon T; Bârsan M
    Rom J Morphol Embryol; 2007; 48(1):11-6. PubMed ID: 17502945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphologic changes in the thymus gland in myasthenia under the effect of radiation therapy].
    Kop'eva TN
    Arkh Patol; 1968; 30(7):13-9. PubMed ID: 5727112
    [No Abstract]   [Full Text] [Related]  

  • 7. Isozymes of AMP-Deaminase in Muscles Myasthenia Gravis Patients.
    Rybakowska IM; Bakuła S; Kaletha K
    Int J Pept Res Ther; 2016; 22(4):511-515. PubMed ID: 27795699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of thymus and results of thymectomy in myasthenia gravis. Correlative clinical, histologic and immunofluorescent studies.
    Bhuyan UN; Prusty S; Singh N
    Indian J Med Res; 1975 Oct; 63(10):1451-8. PubMed ID: 1222958
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of rat AMP deaminase 3 (isoform C) by development and skeletal muscle fibre type.
    Mahnke-Zizelman DK; D'cunha J; Wojnar JM; Brogley MA; Sabina RL
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):521-9. PubMed ID: 9291127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle.
    Fortuin FD; Morisaki T; Holmes EW
    Proc Assoc Am Physicians; 1996 Jul; 108(4):329-33. PubMed ID: 8863347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis: influence of thymic changes on clinical parameters. A study on the basis of 364 thymectomies.
    Szobor A; Molnár J; Szepesházy K
    Acta Med Hung; 1986; 43(3):229-41. PubMed ID: 3588165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
    Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
    Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of human skeletal muscle AMP deaminase deficiency. Evidence of a correlation between the muscle HPRG content and the level of the residual AMP deaminase activity.
    Sabbatini AR; Toscano A; Aguennouz M; Martini D; Polizzi E; Ranieri-Raggi M; Moir AJ; Migliorato A; Musumeci O; Vita G; Raggi A
    J Muscle Res Cell Motil; 2006; 27(1):83-92. PubMed ID: 16570231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Morphology of the thymus gland in children with myasthenia gravis].
    Kop'eva TN; Sekamova SM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):13-7. PubMed ID: 2176031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ultrastructural study of the thymus in patients with myasthenia gravis].
    Li SX; Hu ZL; Zeng LQ
    Zhonghua Nei Ke Za Zhi; 1993 May; 32(5):310-2. PubMed ID: 8269758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial myasthenia gravis: report of 2 brothers].
    de Freitas MR; Gomes SE; Cincinatus D; Garcia JM; Nevares MT; Hahn MD
    Arq Neuropsiquiatr; 1985 Mar; 43(1):80-5. PubMed ID: 4015442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histopathological and histometrical study of the non-neoplastic thymus in myasthenia gravis (author's transl)].
    Oikawa S; Saito S
    Rinsho Shinkeigaku; 1980 May; 20(5):354-9. PubMed ID: 7408337
    [No Abstract]   [Full Text] [Related]  

  • 18. Normal activities of AMP-deaminase and adenylate kinase in patients with McArdle disease.
    Joshi PR; Apitz T; Zierz S
    Neurol Res; 2016 Dec; 38(12):1052-1055. PubMed ID: 27760513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the non-neoplastic thymus in myasthenia gravis].
    Havlicek J
    Cesk Patol; 1983 Aug; 19(3):178-84. PubMed ID: 6627468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent N-terminal regions in AMP deaminase and isoform-specific catalytic properties of the enzyme.
    Bausch-Jurken MT; Sabina RL
    Arch Biochem Biophys; 1995 Aug; 321(2):372-80. PubMed ID: 7646062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.